Qritive Pantheon
by Qritive
· Based in Singapore →
— Leveraging AI to enhance histopathology diagnosis of cancer & the quality of patient care!
Overview
Qritive Pantheon is an artificial intelligence (AI) tool designed for digital pathology. It provides AI-powered image analysis for whole slide images, aiming to assist pathologists in their diagnostic workflows.
- What it does: Qritive Pantheon offers AI algorithms for analyzing digitized tissue slides. It is designed to identify and quantify specific features within pathology images, such as tumor regions, cellular characteristics, and other morphological patterns. The tool processes whole slide images to provide quantitative data and visual overlays.
- Who it is for: This tool is intended for pathologists and pathology laboratories that have adopted digital pathology workflows. It is applicable in care settings where histopathological diagnosis is performed, including hospitals, academic medical centers, and reference laboratories.
- How it fits a clinical or practice workflow: Qritive Pantheon integrates into existing digital pathology platforms. Pathologists can upload whole slide images to the system, which then applies its AI algorithms. The results, including AI-generated annotations and quantitative metrics, are presented to the pathologist, who then reviews and interprets them as part of their diagnostic process. It is designed to be a supplementary tool to aid in the assessment of complex cases or high-volume workloads.
- Notable capabilities: The platform supports various tissue types and disease areas, with specific AI modules tailored for different diagnostic challenges. It aims to enhance efficiency and consistency in image analysis by providing objective, AI-driven insights.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered modules for cancer diagnosis and grading
- Vendor-agnostic digital pathology platform
- Seamless integration into digital pathology workflows
- Case management dashboard
- Advanced slide viewer with diverse magnifying levels
- Telepathology and remote diagnosis support
- Synoptic reporting
- LIS integration
- Open AI format for seamless deployment
- Supports triage and prescreening
Use Cases
- Identifying, grading, and classifying cancer (prostate, colon, lymph node, breast, gastric, immunohistochemistry, blood smears)
- Enhancing histopathology diagnosis of cancer
- Streamlining pathology lab workflows
- Supporting remote diagnosis and telepathology
- Improving diagnostic accuracy and consistency
- Accelerating turnaround times for pathology reports
What Physicians Need to Know
Key Capabilities
Qritive Pantheon is an AI-powered image management system that digitizes and streamlines the entire pathology workflow, from slide viewing and case management to AI-supported diagnosis and structured reporting. It offers AI modules for various cancer types, including breast, prostate, colon cancer, lymph node metastasis, and immunohistochemistry. The platform supports automated AI analysis with a single click and provides tools for easy collaboration among pathologists.
Clinical Utility
Pantheon's AI modules assist pathologists in detecting, grading, and classifying cancers, aiming to improve diagnostic accuracy, consistency, and turnaround time. It helps alleviate the workload of pathologists by automating tedious and time-consuming tasks, such as counting millions of cells. Studies have shown that its immunohistochemistry AI module can reduce pathologists' errors by 9.4%. The platform also supports telepathology and remote diagnosis, which is crucial for labs adopting a hub-and-spoke model.
Integration Options
Pantheon is vendor-agnostic and cloud-ready, supporting all major whole-slide image (WSI) formats. It enables seamless integration with hospital systems, Laboratory Information Systems (LIS), Electronic Medical Records (EMR), and Picture Archiving and Communication Systems (PACS). The platform can be deployed both on-premise and in the cloud.
Compliance Status
Pantheon is CE-IVDD marked and registered as a Class A medical device with the Health Sciences Authority (HSA) in Singapore. Qritive is ISO 13485:2016 certified for Quality Management Systems and ISO/IEC 27001:2022 certified for Information Security Management Systems, ensuring compliance with international medical device standards, data privacy, and operational security.
Pricing Model
The pricing model for Qritive Pantheon is not explicitly detailed but is likely subscription-based, varying by factors such as site volume, traffic, and required features/support. For similar WebOps platforms named Pantheon, pricing can range from approximately $500u2013$1,000 per month for small deployments to $5,000u2013$15,000+ per month for enterprise contracts.
User Experience
Pantheon is designed to be easy to use and adopt, offering a seamless single-window operation with an integrated patient management system. It provides a seamless user experience for pathologists, with features like an advanced slide viewer and case management dashboard.
Support Quality
While specific details on Qritive Pantheon's support quality are not extensively provided, general user reviews for other Pantheon software indicate accessible and responsive customer support, which is often highlighted as a strong advantage.
Implementation Complexity
Pantheon is described as a scalable and interoperable solution that can be flexibly deployed within existing digital pathology workflows. It supports both on-premise and cloud deployment options. However, implementing AI solutions in healthcare can involve challenges related to data anonymization, storage, and the need for systematic evaluation, ongoing calibration, and training for AI models.
Evidence Base
Qritive's AI-powered solutions are rooted in scientific research and have demonstrated effectiveness in increasing the diagnostic confidence of pathologists. A collaborative study with Singapore General Hospital showed a 9.4% reduction in pathologists' errors with their immunohistochemistry AI module. Qritive also collaborates with research institutions on R&D projects for building predictive digital biomarkers.
Physician Tip
Qritive Pantheon offers a comprehensive solution for digital pathology, leveraging AI to enhance diagnostic accuracy and efficiency. Physicians should consider its vendor-agnostic nature and strong integration capabilities for seamless adoption into existing workflows. The AI modules for specific cancer types can significantly aid in identifying and grading malignancies, potentially reducing turnaround times and improving diagnostic consistency. While the platform aims to upskill junior pathologists and automate tedious tasks, ongoing training and evaluation of the AI models are crucial for optimal utilization and to address potential biases. The remote access and telepathology features are particularly beneficial for collaborative diagnostics and supporting hub-and-spoke lab models.
Qritive Pantheon is designed for extensive integration, being vendor-agnostic and compatible with major LIS, EMR, PACS, and other hospital information systems. It supports all widely used whole-slide image (WSI) file formats and offers both on-premise and cloud deployment options. This flexibility allows for seamless incorporation into diverse digital pathology ecosystems, enabling efficient data flow and collaborative workflows without being tied to specific hardware or software vendors.
Details
| Category | Oncology AI, Pathology AI |
| Pricing | Unknown |
| Deployment | Cloud-ready; On-premises and cloud deployment options |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated Qritive's solutions are CE certified and also approved by Singapore Health Sciences Authority (HSA) for clinical use. Pantheon™ is CE-marked and HSA-registered, meeting international medical device standards. The AI Colon module is also registered with HSA under Class A. |
| Integrations | |
| EHR | Not specified |
| Specialties | Dermatology, Oncology, Pathology |
What the Web Says
Qritive Pantheon is an AI-powered image management system designed to digitize and streamline pathology workflows, from slide viewing and case management to AI-supported diagnosis and structured reporting. It aims to improve the speed, accuracy, and affordability of cancer diagnosis by assisting pathologists in analyzing microscopy images and patient data. The platform is CE-marked, HSA Class A registered, vendor-agnostic, and cloud-ready, supporting remote access and telepathology.
Overall: PositiveStrengths
- Enhances diagnostic accuracy and consistency through AI-powered analysis.
- Streamlines the entire pathology lab workflow, from digitization to report generation.
- Reduces diagnostic subjectivity and improves workflow efficiency for pathologists.
- Vendor-agnostic and cloud-ready, allowing for seamless integration with existing hospital systems and remote access.
- Supports various cancer types, including breast, prostate, colon, immunohistochemistry, and lymph node metastasis.
- Potential to reduce diagnostic time and discordance among pathologists.
Limitations
- Insufficient clinical validation studies to prove software and AI module accuracy and effectiveness in clinical diagnosis and screening.
- Implementation challenges related to data anonymization and storage can be time-consuming and costly.
- Requires special training for pathologists and clinicians to utilize effectively.
- Potential for AI model bias and integrity issues, including under-reporting of important demographic information.
Based on reviews from: SourceForge, Singapore's HealthTech firm Qritive aims to improve cancer diagnosis through AI [Q&A], Compare Pantheon vs. Qritive in 2026, Approved - Page 1 of 3 Health Technology Review, Pantheon - Qritive, Qritive | AI-powered digital pathology solutions, Digitizing Pathology with Pantheonu2122 - Qritive, Qritive: Leveraging AI to enhance histopathology diagnosis of cancer & the quality of patient care! - Nasscom CoE IoT, Qritive partners with Metropolis, Cu014cRE Diagnostics, and Rajiv Gandhi Cancer Institute to drive AI adoption in pathology Across India, ETHealthworld, Advancing Cancer Diagnostics with Qritive's AI Modules
Last updated: 2026-07-09
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Qritive Pantheon
Press & Coverage
Tissuepathology.com
Qritive's Pantheon receives Class A Medical Device registration from Health Sciences Authority Singapore
Qritive's Pantheon, a digital pathology platform with AI plugins for cancer diagnosis, received Class A Medical Device registration from the Health Sciences Authority Singapore (HSA) in July 2020. This allows Pantheon to be used for clinical purposes in Singapore and India, and for research in other countries.
2020-07
BioPharma APAC
Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets
Qritive raised $7.5 million in Series A funding in January 2023 to support geographical expansion, product portfolio growth, and regulatory clearances. The funding round was led by MassMutual Ventures, with participation from SEEDS Capital and Exfinity Venture Partners.
2023-01
Entrepreneur India
Healthcare AI Firm Qritive Raises $7.5 Million
Qritive secured $7.5 million in a funding round in January 2023, led by MassMutual Ventures, SEEDS Capital, and Exfinity Venture Partners, to drive global expansion, enhance its product offerings, and obtain further regulatory approvals. The company's Pantheon platform is designed to accelerate cancer diagnosis across various types.
2023-01
Lumea
Top 10 AI Companies for Digital Pathology (2026)
Qritive is listed among the top AI companies for digital pathology in 2026, offering AI-powered modules that assist pathologists in identifying, grading, and classifying various cancers. These modules are hardware-agnostic and integrate with digital pathology workflows, including Qritive's Pantheonu2122.
2026-07
Journal of Pathology and Translational Medicine (via PMC)
Improving the accuracy of reporting Ki-67 IHC by using an AI tool
A study published in November 2024 utilized Qritive Pantheon's annotation software to draw regions of interest for improving the accuracy of Ki-67 IHC reporting using an AI tool. The AI algorithm identified and categorized nuclei based on IHC staining intensity.
2024-11
Fashion Passion (reprinting a press release)
AI-Enabled Pathologists: RGCIRC Speeds up Cancer Diagnosis
Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) adopted Qritive's Pantheon, which includes AI modules for various cancers like Lymphoma, Prostate, Gastric, Colon, and Breast, to reduce the turnaround time for cancer diagnosis from weeks to a day.
2023-07
Journal of Pathology Informatics (via ResearchGate)
Image Analysis Using Machine Learning for Automated Detection of Hemoglobin H Inclusions in Blood Smears - A Method for Morphologic Detection of Rare Cells
A peer-reviewed article from April 2021 discusses the use of Qritive Pantheonu2122 as a whole slide image viewer to inspect and annotate digital images and view predictions made by AI software for automated detection of Hemoglobin H inclusions in blood smears.
2021-04
SGInnovate
Keeping an Eye on Cancer
An article from June 2020 highlights Qritive's Pantheon, which uses advanced Machine Learning and intelligent image analysis to identify complex patterns in tissue and blood samples for cancer diagnosis. The platform also employs natural language processing to process patient data.
2020-06
Videos
Product demos, reviews, and walkthroughs for Qritive Pantheon.
Championing Digital Pathology
InnovatorMD
Frequently Asked Questions
Qritive Pantheon is an AI-powered image management system designed to digitize and streamline the entire pathology workflow. It offers features like slide viewing, case management, AI-supported diagnosis, and structured reporting. Pantheon is vendor-agnostic and cloud-ready, supporting remote access, telepathology, and seamless integration with existing hospital systems and LIS.
Qritive Pantheon integrates with Qritive's suite of AI diagnostic modules that support pathologists in identifying, grading, and classifying various cancers with precision. These modules include solutions for prostate and colon cancer, lymph node metastasis, and biomarker analysis.
Qritive upholds high standards for security, data protection, and regulatory compliance. Pantheon is CE-marked and registered with the Health Sciences Authority (HSA) in Singapore, ensuring compliance with international medical device standards. The platform is developed under ISO 13485 and complies with global standards like ISO 14971 and IEC 62304, with ISO 27001 certification for data encryption and secure access.
While Qritive Pantheon offers significant advantages, some reported limitations include insufficient clinical validation studies to fully prove the software and AI module accuracy and effectiveness in all clinical diagnoses and screenings. Challenges also exist in AI module development due to the availability and quality of imaging data, and the need for special training for pathologists and clinicians to utilize the system effectively.
Yes, there are several other AI-powered digital pathology platforms available. Some notable alternatives include Ibex Medical Analytics, Aiforia, AIRA Matrix, and Panakeia. Other platforms like Tempus Digital Pathology, PathAI AISight, and Proscia Concentriq also offer AI-powered solutions for digital pathology workflows.
Specific pricing details for Qritive Pantheon are not publicly available. However, similar to other enterprise-grade WebOps platforms, pricing for Pantheon is likely structured around variables such as the number of sites, expected traffic volume, and the level of support and features required. It's common for such platforms to offer tiered plans ranging from basic hosting to enterprise-grade infrastructure with negotiated pricing for larger deployments.
Suggest an Edit →
| Last Verified: 2026-07-09 | First Added: 2026-07-09